Publication
Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma.
Blood
Henriquez S, Zerbit J, Bruel T, Ouedrani A, Planas D, Deschamps P, Staropoli I, Hadjadj J, Varet B, Ermak N, Bouscary D, Willems L, Fouquet G, Decroocq J, Franchi P, Deau-Fischer B, Terrier B, Tamburini J, Chatenoud L, Schwartz O, Vignon M,